Daljeet S Kohli, Head of Research at Indianivesh Securities feels that Indoco Remedies may touch Rs 392.
Daljeet S Kohli, Head of Research at Indianivesh Securities is bullish on Pennar Industries.
According to Daljeet S Kohli, Head of Research at Indianivesh Securities, Capital First may move to Rs 400.
Daljeet S Kohli, Head of Research at Indianivesh Securities feels that Mastek may go to Rs 554.
Indian equities have seen a sharp rebound, aided largely by policy and positive global factors. Measures announced by the new RBI governor have brought stability to the rupee.